The tweet was deleted by the author.
But we saved everything 🙂.
NVEC emerged as the top stock gainer in the previous trading session, according to NVE.
The outperformance was recognized by market tracking platform TradingView, though no specific percentage or price movement details were provided. Investors are monitoring NVEC’s momentum amid increased interest in leading equity risers. Details are being clarified.
NVE recently reported new research on noninvasive hemoglobin measurement using an NVE sensor, as published in the AIP Conference Proceedings. The company also introduced a method to measure hemoglobin with a proprietary sensor, instrumentation amplifier, and Arduino platform in a separate release earlier this year. These developments have drawn investor interest to NVE’s technology portfolio.